diseases, but little is known about its impact on the incidence of infections and immune
reconstitution. We examined the pattern and outcome of cytomegalovirus (CMV) infections
monitored by polymerase chain reaction–based assays and treated preemptively in 101
patients following nonmyeloablative conditioning containing in vivo Campath-1H. Fifty-one
patients (50%) had a CMV infection at a median of 27 days after transplantation with a …